Industry News
Alcon Launches PRECISION7: First One-Week Contact Lens with ACTIV-FLO Technology

Alcon has announced the U.S. launch of PRECISION7, a groundbreaking contact lens designed for a conv...

read more
Alcon Launches PRECISION7: First One-Week Contact Lens with ACTIV-FLO Technology
November 12, 2024
Konan Medical USA Launches objectiveFIELD Visual Field Analyzer

Konan Medical USA has officially launched the objectiveFIELD (OFA) visual field analyzer, a new devi...

read more
Konan Medical USA Launches objectiveFIELD Visual Field Analyzer
November 12, 2024
Noninvasive Choroidal Vessel Analysis Using Deep Learning: A Novel OCT Angiography Technique

Researchers from Peking University have pioneered a noninvasive choroidal angiography technique that...

read more
Noninvasive Choroidal Vessel Analysis Using Deep Learning: A Novel OCT Angiography Technique
November 12, 2024
AlloVir and Kalaris Therapeutics Announce Merger to Advance Retinal Disease Treatments

In a strategic move aimed at advancing therapies for retinal diseases, AlloVir has announced a defin...

read more
AlloVir and Kalaris Therapeutics Announce Merger to Advance Retinal Disease Treatments
November 11, 2024
Neurotech Provides Update on BLA for NT-501 as Treatment for Macular Telangiectasia Type 2

Neurotech Pharmaceuticals has released an update regarding its biologics license application (BLA) f...

read more
Neurotech Provides Update on BLA for NT-501 as Treatment for Macular Telangiectasia Type 2
November 11, 2024
De-escalated Adjuvant Chemotherapy Proves Effective for High-Risk Retinoblastoma

A recent study reveals that a shortened adjuvant chemotherapy regimen offers similar efficacy and im...

read more
De-escalated Adjuvant Chemotherapy Proves Effective for High-Risk Retinoblastoma
November 11, 2024
Eye-Tracking Study Reveals Retinal Mechanisms Behind Visual Stability

A recent eye-tracking study led by Prof. Markus Lappe from the University of Münster has uncovered n...

read more
Eye-Tracking Study Reveals Retinal Mechanisms Behind Visual Stability
November 08, 2024
Clearside Biomedical’s Partner Arctic Vision Signs Commercial Collaboration with Santen for ARVN001 in China

Clearside Biomedical has announced that Arctic Vision, its Asia-Pacific partner, has signed a commer...

read more
Clearside Biomedical’s Partner Arctic Vision Signs Commercial Collaboration with Santen for ARVN001 in China
November 08, 2024
Study Links Socioeconomic Deprivation to Severity of Rhegmatogenous Retinal Detachment

A recent study indicates that patients living in socioeconomically deprived neighborhoods are more l...

read more
Study Links Socioeconomic Deprivation to Severity of Rhegmatogenous Retinal Detachment
November 08, 2024
Formosa Pharmaceuticals Announces Top-Line Results from Phase 3 Trial of APP13007 in China

Formosa Pharmaceuticals recently announced the completion of CPN-303, a Phase 3 clinical trial condu...

read more
Formosa Pharmaceuticals Announces Top-Line Results from Phase 3 Trial of APP13007 in China
November 07, 2024
More